Appendix B

Statement of Task

An ad hoc planning committee will plan and conduct a public workshop that will explore commonalities across neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal dementia, and identify potential opportunities for collaboration across the respective research and development communities. Participants will be invited from academia; pharmaceutical and biotechnology industries; government agencies such as the National Institutes of Health, the National Science Foundation, and the Department of Veterans Affairs; and patient advocacy groups. Looking across the neurodegenerative diseases, workshop presentations and discussions will

 

•    Identify and discuss commonalities related to genetic and cellular mechanisms.

•    Identify areas of fundamental science needed to facilitate therapeutics development.

•    Explore areas of potential collaboration among the respective research communities and sponsors.

 

An individually authored workshop summary will be prepared based on the information gathered and the discussions held during the workshop in accordance with institutional policy and procedures.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 77
Appendix B Statement of Task An ad hoc planning committee will plan and conduct a public work- shop that will explore commonalities across neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral scle- rosis, and frontotemporal dementia, and identify potential opportunities for collaboration across the respective research and development communities. Participants will be invited from academia; pharmaceutical and biotech- nology industries; government agencies such as the National Institutes of Health, the National Science Foundation, and the Department of Veterans Affairs; and patient advocacy groups. Looking across the neurodegenerative diseases, workshop presentations and discussions will • Identify and discuss commonalities related to genetic and cellular mechanisms. • Identify areas of fundamental science needed to facilitate therapeu- tics development. • Explore areas of potential collaboration among the respective research communities and sponsors. An individually authored workshop summary will be prepared based on the information gathered and the discussions held during the workshop in accordance with institutional policy and procedures. 77

OCR for page 77